Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Top 10 Copper-producing Companies (Updated 2024)

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Rare Earths Reserves: Top 8 Countries (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Top 10 Countries for Natural Gas Production (Updated 2024)

Top 5 Junior Gold Stocks on the TSXV in 2024

A State-by-State Guide to Cannabis in Australia

Silver Price Update: Q1 2024 in Review

Trending Press Releases

Indicative, Conditional and Non-Binding Proposal Received by American Rare Earths

Purepoint Uranium Group Inc. Launches Strategic Drill Program at Turnor Lake Project Targeting the La Rocque Structural Corridor

Beyond Lithium and Its Exploration Team Recognized with Bernie Schnieders Discovery of the Year Award

Freegold Announces Start of 2024 Drilling Program at Golden Summit

Falco Resources: Canadian Explorer in the Rouyn-Noranda Mining Camp

Argentina Lithium Announces Positive Lithium Values in the 12th Exploration Well at the Rincon West Project

More Press Releases
Trending Companies

Jindalee Lithium

JLL:AU

Rio Silver

RYO:CA

Falco Resources

FPC:CC

NorthStar Gaming Holdings

BET:CC
More Companies
Trending Reports

Lithium Outlook for Australia

2024 Gold Outlook Report

2024 Uranium Outlook (Updated for Q2)

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Orchard Therapeutics plc

NGS:ORTX
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company.
Press Releases
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.
×